arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Travere Therapeutics, Inc.

TVTX Health Care Biotechnology: Pharmaceutical Preparations
$45.81
▼ -0.8% Today
as of Jun 7, 07:30 ET
Last 30 days +12.03% Apr 28 → Jun 05
$39.49 $41.71 $43.93 $46.15 $48.37 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$46.50
High
$47.77
Low
$45.30
Volume
$3M
Avg Vol
$2M
Mkt Cap
$4.4B
P/E (TTM)
Beta
52w High
$48.61
52w Low
$13.88
Div Yield
Shares Out
$92M

Overview

52-week range
$14
$49
92% of range
Avg surprise (last 2)
-7.7%
Avg reaction (last 2)
+0.8%
50% positive
Latest IV / EM
67%
EM ±9.3% · $45 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.76$-0.83$0.10$1.04$1.97 Actual $-1.13Actual $1.97Actual $-1.76Actual $-0.91Actual $-0.70Actual $-0.47Est $-0.55Actual $-0.14Actual $0.28Actual $-0.39Est $-0.30 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-70M$-46M$-22M$3M$27M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 4, 2026Mar/2026 $-0.39 $-0.30 -30.0% +17.0% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $0.28 financials
Mon Jun 30, 2025Jun 2025 $-0.14 financials
Thu May 1, 2025Mar/2025 $-0.47 $-0.55 +14.6% -0.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.70 financials
Sun Jun 30, 2024Jun 2024 $-0.91 financials
Sun Mar 31, 2024Mar 2024 $-1.76 financials
Sat Sep 30, 2023Sep 2023 $1.97 financials
Fri Jun 30, 2023Jun 2023 $-1.13 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$2M$2M$2M$5M$2M$2M
Gross profit
Operating income$-37M$25M$-13M$-43M$-56M$-68M
Net income$-37M$26M$-13M$-41M$-55M$-70M
EPS (diluted)$-0.40$0.28$-0.14$-0.47$-0.70$-0.91

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$78M$93M$111M$75M$62M$59M$36M$32M
Inventory$37M$36M$38M$38M$38M$42M$43M$43M
Total current assets$393M$438M$371M$380M$374M$417M$325M$369M
Total assets$555M$605M$539M$555M$549M$594M$504M$551M
Long-term debt
Total liabilities$456M$490M$465M$523M$516M$535M$535M$536M
Total equity$99M$115M$74M$33M$33M$59M$-30M$15M

Implied volatility — last 90 days

62%64%67%69%72% Jun 07 — IV 67% · EM ±9.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.